Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06170762
Other study ID # 800
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 20, 2023
Est. completion date January 20, 2025

Study information

Verified date December 2023
Source Minia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sodiumhexametaphosphate will be used as capping material for dental pulp of immature permanent teeth


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date January 20, 2025
Est. primary completion date December 20, 2024
Accepts healthy volunteers No
Gender All
Age group 7 Years to 10 Years
Eligibility Inclusion Criteria: - healthy children - cooperative children - deep carious lesion - traumatic pulp exposure - immature permanent teeth Exclusion Criteria: - uncooperative children - children with systemic disorders - non vital immature permanent teeth

Study Design


Intervention

Other:
Pulp capping
Pulp capping material for immature permanent teeth in case of carious or traumatic pulp expures
Drug:
Sodiumhexametaphosphate
Sodiumhexametaphosphate
Other:
MTA
MTA

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical success Absence of pain, tenderness, mobility and swelling One year
Primary Radiographic success Absence of periapical lesions, internal resorption an external resorption also evidence of continuous root growth One year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06467890 - Knowledge of Vital Pulp Therapy in Permanent Teeth After Educational Programme: A Before and After Study
Not yet recruiting NCT05981352 - Evaluation of Different Materials in Pulpotomy of Primary Molars N/A
Recruiting NCT06227390 - Clinical and Radiographic Outcomes of Partial Pulpotomy Procedure in Primary Molars Utilizing Different Capping Materials and Different Restorative Methods N/A
Completed NCT06398327 - Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy N/A
Recruiting NCT03883295 - Evaluation of Clinical and Radiological Success of Vital Amputation Treatment N/A
Active, not recruiting NCT03580135 - Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars Phase 2
Recruiting NCT03410134 - Assessment of Vital Pulp Therapy in Permanent Molars N/A
Recruiting NCT04793477 - Effectiveness of Rotating System and Single File Reciprocating System in Temporal Molars N/A
Completed NCT04274920 - Dentin Bridge Formation After Indirect Pulp Capping With Bioactive Glass Incorporated in Resin Composite and Its Adhesive in Comparison With Light Cured Calcium Hydroxide N/A
Not yet recruiting NCT05839548 - Articaine Efficacy and Safety for 3 Years Old Children Phase 3
Active, not recruiting NCT05912907 - Potassium Nitrate in Polycarboxylate as a Direct Pulp Capping N/A
Completed NCT05633537 - Clinical & Radiographic Evaluation of Zinc Oxide-Ozonated Oil as a New Primary Root Canal Filling N/A
Completed NCT06110494 - A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment Phase 4
Completed NCT03542019 - Survival of Endocrowns Made From Different Ceramics N/A
Completed NCT06002646 - Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques Phase 4
Not yet recruiting NCT03368391 - : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic Phase 4
Recruiting NCT06196515 - Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication Phase 2/Phase 3
Not yet recruiting NCT04650113 - Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA Phase 1/Phase 2
Completed NCT06129643 - Post-operative Pain After Laser Root Canal Treatment of Necrotic Teeth With Apical Periodontitis Phase 2
Recruiting NCT06207253 - The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament Phase 2/Phase 3